文献速递心外重症与机械循环支持先天性心脏病外科

体外搏动式EXCOR装置为儿童和成人终末期心衰提供持久循环支持

Durable circulatory support with a paracorporeal device as an option for pediatric and adult heart failure patients.
PubMed 文献 · J Thorac Cardiovasc Surg · 2020-05-15

该回顾性单中心研究纳入2008至2018年50例(21例儿童、29例成人)接受体外EXCOR作为移植或心肌恢复过渡的患者,多数为INTERMACS 1级。结论认为尽管病情危重,EXCOR生存率高,但血栓栓塞、机械故障和感染仍是主要问题。

要点

  • 体外EXCOR可为小体重儿童、复杂先心青少年及双心室衰竭成人提供持久循环支持。
  • 儿童5年生存率90%,成人75%,双心室与单心室辅助生存率无显著差异。

核心结论

  • 尽管患者病情危重,EXCOR支持期间生存率高,心脏移植及心肌恢复后长期总体生存概率具有优势。
  • 治疗安全性尚可,但仍受血栓栓塞、机械故障和感染影响。

研究设计与样本

  • 回顾性收集2008至2018年50例接受EXCOR作为心脏移植或心肌恢复过渡的患者临床数据、超声心动图、有创血流动力学及手术信息。
  • 队列包括21例儿童和29例成人,比较不同组间差异。

主要发现

  • 多数患者心衰符合INTERMACS 1级。

关键数值与推荐

  • EXCOR适用于不适合连续流左心室辅助装置的患者,包括小体重儿童、复杂先天性心脏病青少年和双心室衰竭成人。

临床怎么用

  • 对于不适合连续流左心室辅助装置的小体重儿童、复杂先心青少年及双心室衰竭成人,可考虑体外EXCOR作为移植或恢复过渡。
  • 需警惕血栓栓塞、机械故障(腔室血栓、膜破裂)和感染,并加强相应监测与管理。

局限性

  • 回顾性单中心研究,样本量50例,组间比较可能受混杂因素影响。
  • 原文未报告具体P值校正方法、随访完整性和多变量分析结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Not all patients in need of durable mechanical circulatory support are suitable for a continuous-flow left ventricular assist device. We describe patient populations who were treated with the paracorporeal EXCOR, including children with small body sizes, adolescents with complex congenital heart diseases, and adults with biventricular failure. METHODS: Information on clinical data, echocardiography, invasive hemodynamic measurements, and surgical procedures were collected retrospectively. Differences between various groups were compared. RESULTS: Between 2008 and 2018, a total of 50 patients (21 children and 29 adults) received an EXCOR as bridge to heart transplantation or myocardial recovery. The majority of patients had heart failure compatible with Interagency Registry for Mechanically Assisted Circulatory Support profile 1. At year 5, the overall survival probability for children was 90%, and for adults 75% (P = .3). After we pooled data from children and adults, the survival probability between patients supported by a biventricular assist device was similar to those treated with a left ventricular assist device/ right ventricular assist device (94% vs 75%, respectively, P = .2). Patients with dilated cardiomyopathy had a trend toward better survival than those with other heart failure etiologies (92% vs 70%, P = .05) and a greater survival free from stroke (92% vs 64%, P = .01). Pump house exchange was performed in nine patients due to chamber thrombosis (n = 7) and partial membrane rupture (n = 2). There were 14 cases of stroke in eleven patients. CONCLUSIONS: Despite severe illness, patient survival on EXCOR was high, and the long-term overall survival probability following heart transplantation and recovery was advantageous. Treatment safety was satisfactory, although still hampered by thromboembolism, mechanical problems, and infections.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Bartfay SE, Dellgren G, Hallhagen S, et al. Durable circulatory support with a paracorporeal device as an option for pediatric and adult heart failure patients. J Thorac Cardiovasc Surg. 2020. PMID: 32653285. doi:10.1016/j.jtcvs.2020.04.163

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。